The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Lyxor JPX-Nikkei 400 (DR) UCITS ETF - Acc: Net Asset Value(s)

7 Apr 2020 17:18

Lyxor JPX-Nikkei 400 (DR) UCITS ETF - Acc (JPXG LN) Lyxor JPX-Nikkei 400 (DR) UCITS ETF - Acc: Net Asset Value(s) 07-Apr-2020 / 18:18 CET/CEST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Net Asset Value(s)

FUND: Lyxor JPX-Nikkei 400 (DR) UCITS ETF - Acc

DEALING DATE: 06-Apr-2020

NAV PER SHARE: EUR: 135.094

NUMBER OF SHARES IN ISSUE: 1747448

CODE: JPXG LN

ISIN: LU1646359452


ISIN:LU1646359452
Category Code:NAV
TIDM:JPXG LN
Sequence No.:57126
EQS News ID:1017883
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.